Towards the discovery of drug-like RNA ligands?
- 30 November 2006
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 11 (21-22) , 1019-1027
- https://doi.org/10.1016/j.drudis.2006.09.001
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Functional, Biophysical, and Structural Bases for Antibacterial Activity of TigecyclineAntimicrobial Agents and Chemotherapy, 2006
- Binding of Neomycin-Class Aminoglycoside Antibiotics to Mutant Ribosomes with Alterations in the A Site of 16S rRNAAntimicrobial Agents and Chemotherapy, 2006
- Non-coding RNAs: New players in eukaryotic biologyPublished by Elsevier ,2005
- Validation of Automated Docking Programs for Docking and Database Screening against RNA Drug TargetsJournal of Medicinal Chemistry, 2004
- Rational Design of Inhibitors of HIV-1 TAR RNA through the Stabilisation of Electrostatic “Hot Spots”Journal of Molecular Biology, 2004
- Structure of TAR RNA Complexed with a Tat-TAR Interaction Nanomolar Inhibitor that Was Identified by Computational ScreeningChemistry & Biology, 2002
- The Search and Its Outcome: High-Resolution Structures of Ribosomal Particles from Mesophilic, Thermophilic, and Halophilic Bacteria at Various Functional StatesAnnual Review of Biophysics, 2002
- Biochemical and kinetic characteristics of the interaction of the antitumor antibiotic sparsomycin with prokaryotic and eukaryotic ribosomesBiochemistry, 1991
- Recognition of the highly conserved GTPase center of 23 S ribosomal RNA by ribosomal protein L11 and the antibiotic thiostreptonJournal of Molecular Biology, 1991
- Binding of spectinomycin by ribosomes fromEscherichia coliCurrent Microbiology, 1990